Navigation Links
Science Magazine to Host Webinar on Advances in Cancer Genomics
Date:4/15/2009

by the combination of Invitrogen Corporation and Applied Biosystems, Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com.

About Science
Founded in 1880 by Thomas Edison and published by the American Association for the Advancement of Science (AAAS), Science ranks as the world's largest general science journal. Each week, Science provides more than 131,000 global subscribers with peer-reviewed original research, scientific research articles, science and research news, and more.

About AAAS
The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society, and publisher of the journal, Science (www.sciencemag.org). AAAS was founded in 1848, and includes some 262 affiliated societies and academies of science, serving 10 million individuals. The nonprofit AAAS (www.aaas.org) is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy, international programs, science education, and more. For the latest research news, log onto EurekAlert! at www.eurekalert.org, the premier science news website, a service of AAAS.

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2321844.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
7. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
8. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
9. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, a global ... and manufacture of highly valued cardiac markers used in early detection of heart ... protein chemistry has led to the development and commercialization of important cardiac biomarkers ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic ... it has received a $1.5M Phase II SBIR ... to further develop its therapeutic agent to reduce ... need in end stage renal disease (ESRD) patients ... National Institute of Diabetes and Digestive and Kidney ...
(Date:8/26/2015)... BEIJING , August 26, 2015 Israel ... DiaCardio wins 1 st place  Wayerz comes ... in Israel by venture capital fund JVP, ... including the US, China , Israel ... America .  Impressive achievement for the Israeli representatives ...
(Date:8/26/2015)... OXFORD, England , August 26, 2015 ... P2i Ltd against Europlasma NV relating to P2i ... parties have resolved their dispute in the United ... or liability on the part of either party. As a ... the Central District of California dismissed ...
Breaking Biology Technology:Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6P2i Settles United States Litigation 2
... Bionovo, Inc.,(Nasdaq: BNVI ) today announced financial results ... 2007. Third Quarter Results The company reported ... $243,375 compared to $3,750 for the same period in ... 2006, representing our,National Institute of Health grant drawdown from ...
... SEATTLE, Nov. 12 Trubion Pharmaceuticals Inc.,(Nasdaq: ... third quarter and,nine months ended Sept. 30, 2007. ... Revenue for the third quarter and nine ... $14.5 million, respectively, compared with $16.5 million,and $30.2 ...
... Nov. 12 GeoPharma, Inc. (Nasdaq:,GORX) (the "Company") ... from the FDA to begin producing Carprofen. ... a,non-steroidal anti-inflammatory drug (NSAID) that is used by ... with osteoarthritis in,dogs. Additionally, Carprofen is often used ...
Cached Biology Technology:Bionovo Announces Third Quarter 2007 Financial Results 2Bionovo Announces Third Quarter 2007 Financial Results 3Bionovo Announces Third Quarter 2007 Financial Results 4Bionovo Announces Third Quarter 2007 Financial Results 5Bionovo Announces Third Quarter 2007 Financial Results 6Bionovo Announces Third Quarter 2007 Financial Results 7Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results 2Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results 3Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results 4Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results 5Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results 6GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen 2GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen 3
(Date:8/4/2015)... , Aug. 04, 2015 ... ) has announced the addition of the ... Software, and Service), Sub-Segment (Computer Forensics, Network ... Tool Types, Service, Vertical and Region - ... their offering. By Component (Hardware, ...
(Date:7/31/2015)... SHENZHEN , Kina, 31. juli 2015 ... ) bliver afholdt af BGI fra den 22. - 25. ... Konferencen fejrer sin 10-års fødselsdag i år. ... verdens mest indflydelsesrige årlige møder på ,omik,-feltet, og er ... forsamlinger. ICG-10 fokuserer på nylige gennembrud ...
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... -- A microscopic gene may play a gigantic role when ... to one Kansas State University research team. The team ... Disintegrin and Metalloprotease family, or ADAM family, and its role ... is a good guy or a bad guy in breast ...
... UCLA researchers have taken mammalian genome maps, including human maps, one ... fall in the genome but which genes actually interact. ... journal Genome Research, will help researchers better understand which ... help cells thrive or die. Mammals, including ...
... This release is available in German . ... look for allies. This is why physicists from different scientific ... to place the fight against cancer through heat treatment by ... is the objective of the cooperation to improve the success ...
Cached Biology News:K-State research team investigates mutated gene's role in breast cancer 2UCLA scientists map all mammalian gene interactions 2UCLA scientists map all mammalian gene interactions 3How many nanoparticles heat the tumor? 2How many nanoparticles heat the tumor? 3
RABBIT ANTI D-TYROSINE CONJUGATE...
UV LAMP 254 NM 8 WATT, 1 EA. Category: Nucleid Acid Detection Systems....
UV LAMP 300 NM 8W T5, 1 EA. Category: Nucleid Acid Detection Systems....
... The SelectFX Alexa Fluor 488 Cytochrome c ... you need to detect cytochrome c in ... c primary antibody and an Alexa ... 488 dye exhibits bright green fluorescence that ...
Biology Products: